AAAAAA
Results: 1-25/29
Authors:
Mazieres, B
Bannwarth, B
Dougados, M
Lequesne, M
Citation: B. Mazieres et al., EULAR recommendations for the management of knee osteoarthritis. Report ofa task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials, JOINT BONE, 68(3), 2001, pp. 231-240
Authors:
Pehourcq, F
Matoga, M
Jarry, C
Bannwarth, B
Citation: F. Pehourcq et al., Study of the lipophilicity of arylpropionic non-steroidal anti-inflammatory drugs. A comparison between LC retention data on a polymer-based column and octanol-water partition coefficients, J LIQ CHR R, 24(14), 2001, pp. 2177-2186
Authors:
Bannwarth, B
Bertin, P
Pehourcq, F
Schaeverbeke, T
Gillet, P
Lefrancois, G
Treves, R
Dehais, J
Netter, P
Gaucher, A
Citation: B. Bannwarth et al., Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin single, INT J CL PH, 39(1), 2001, pp. 33-36
Authors:
Bannwarth, B
Bertin, P
Queneau, P
Citation: B. Bannwarth et al., Strong opioids for chronic non-cancer pain, PRESSE MED, 30(19), 2001, pp. 947-950
Authors:
Bannwarth, B
Pehourcq, F
Citation: B. Bannwarth et F. Pehourcq, Treatment of osteoarthritis in the elderly: how should paracetamol be prescribed?, PRESSE MED, 30(10), 2001, pp. 498-498
Authors:
Lagrange, F
Fabre, T
Pehourcq, F
Durandeau, A
Bannwarth, B
Citation: F. Lagrange et al., In vitro distribution of ketoprofen enantiomers in articular tissues of osteoarthritic patients, J PHARM B, 26(5-6), 2001, pp. 717-723
Authors:
Bannwarth, B
Citation: B. Bannwarth, COX-2 specific inhibitors: Are NSAIDs and the stomach become reconciled?, GASTRO CL B, 25(4), 2001, pp. B79-B84
Authors:
Bannwarth, B
Citation: B. Bannwarth, Opioids for osteoarthritis of the hip and knee: Which opioids for which patients?, J RHEUMATOL, 28(8), 2001, pp. 1930-1930
Authors:
Bannwarth, B
Pehourcq, F
Lagrange, F
Matoga, M
Maury, S
Palisson, M
Le Bars, M
Citation: B. Bannwarth et al., Single and multiple dose pharmacokinetics of acetaminophen (paracetamol) in polymedicated very old patients with rheumatic pain, J RHEUMATOL, 28(1), 2001, pp. 182-184
Authors:
Pehourcq, F
Jarry, C
Bannwarth, B
Citation: F. Pehourcq et al., Chiral resolution of flurbiprofen and ketoprofen enantiomers by HPLC on a glycopeptide-type column chiral stationary phase, BIOMED CHRO, 15(3), 2001, pp. 217-222
Authors:
Bannwarth, B
Citation: B. Bannwarth, Are COX-2 inhibitors as effective as conventional NSAIDs in acute pain states?, ARCH IN MED, 161(1), 2001, pp. 127-127
Authors:
Lagrange, F
Pehourcq, F
Matoga, M
Bannwarth, B
Citation: F. Lagrange et al., Binding of ketoprofen enantiomers in various human albumin preparations, J PHARM B, 23(5), 2000, pp. 793-802
Authors:
Le Bars, M
Glowinski, J
Bannwarth, B
Citation: M. Le Bars et al., Experimental and clinical aspects of opioid tolerance, physical dependenceand addiction, THERAPIE, 55(3), 2000, pp. 343-347
Authors:
Bannwarth, B
Citation: B. Bannwarth, Gastrointestinal tolerability of nonsteroidal anti-inflammatory drugs, DRUGS, 59, 2000, pp. 17-23
Authors:
Pendleton, A
Arden, N
Dougados, M
Doherty, M
Bannwarth, B
Bijlsma, JWJ
Cluzeau, F
Cooper, C
Dieppe, PA
Gunther, KP
Hauselmann, HJ
Herrero-Beaumont, G
Kaklamanis, PM
Leeb, B
Lequesne, M
Lohmander, S
Mazieres, B
Mola, EM
Pavelka, K
Serni, U
Swoboda, B
Verbruggen, AA
Weseloh, G
Zimmermann-Gorska, I
Citation: A. Pendleton et al., EULAR recommendations for the management of knee osteoarthritis: report ofa task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT), ANN RHEUM D, 59(12), 2000, pp. 936-944
Authors:
Bannwarth, B
Citation: B. Bannwarth, The number needed to be treated as a valuable parameter in interpreting clinical trial findings, REV RHUM, 66(6), 1999, pp. 361-362
Authors:
Bannwarth, B
Citation: B. Bannwarth, Is the WHO analgesic ladder for cancer pain management appropriate for rheumatology patients?, REV RHUM, 66(5), 1999, pp. 241-244
Authors:
Blanco, P
Schaeverbeke, T
Baillet, L
Lequen, L
Bannwarth, B
Dehais, J
Citation: P. Blanco et al., Chondrosarcoma in a patient with McCune-Albright syndrome - Report of a case, REV RHUM, 66(3), 1999, pp. 177-179
Authors:
Bannwarth, B
Citation: B. Bannwarth, Antimicrobial effects of antiinflammatory drugs, antiinflammatory effects of antimicrobial drugs, REV RHUM, 66(1), 1999, pp. 73S-76S
Authors:
Perrot, S
Bannwarth, B
Bertin, P
Javier, RM
Glowinski, J
le Bars, M
Treves, R
Citation: S. Perrot et al., Use of morphine in nonmalignant joint pain: the Limoges recommendations, REV RHUM, 66(11), 1999, pp. 571-576
Authors:
Bannwarth, B
Citation: B. Bannwarth, NSAID COX-2 selective inhibitors: hopes and incertitudes, PRESSE MED, 28(22), 1999, pp. 1180-1181
Authors:
Bannwarth, B
Lagrange, F
Pehourcq, F
Llanas, B
Demarquez, JL
Citation: B. Bannwarth et al., (S)-ketoprofen accumulation in premature neonates with renal failure who were exposed to the racemate during pregnancy, BR J CL PH, 47(4), 1999, pp. 459-460
Authors:
Bannwarth, B
Berenbaum, F
Citation: B. Bannwarth et F. Berenbaum, New non steroidal anti-inflammatory drugs: NO-releasing compounds and selective COX-2 inhibitors., REV MED IN, 20, 1999, pp. 341S-345S
Authors:
Bannwarth, B
Citation: B. Bannwarth, Risk-benefit assessment of opioids in chronic noncancer pain, DRUG SAFETY, 21(4), 1999, pp. 283-296
Authors:
Vignon, E
Bannwarth, B
Conrozier, T
Derobert, E
Verdoncq, B
Citation: E. Vignon et al., Multicenter, double-blind, clinical trial comparing two tablets bid to onetablet qid of the same acetaminophen-dextropropoxyphen-caffeine combination in patients with osteoarthritis., SEM HOP PAR, 75(13-14), 1999, pp. 419-425